期刊文献+

Survivin基因在乳腺癌中的研究

下载PDF
导出
摘要 乳腺癌是威胁女性健康最常见的恶性肿瘤。乳腺癌的发生是受多种因子参与细胞增殖、分化及凋亡异常的过程。凋亡调控失常是肿瘤形成的机制之一,Survivin基因是一种凋亡抑制因子,具有肿瘤特异性,在许多肿瘤组织中高表达,而正常分化的成人组织中检测不出[1]。它抑制癌细胞的凋亡,间接或直接促进乳腺癌的发生发展。本文就Survivin 基因作用机制、结构及在乳腺癌中的表达及意义做一综述。
出处 《河北医药》 CAS 2013年第18期2834-2835,共2页 Hebei Medical Journal
  • 相关文献

参考文献15

  • 1Athanassiadou AM, Patsouris E, Tsipis A, et al. The significance of Sur- vivin and Neetin-4 expression in the prognosis of breast carcinoma. Folia Histoehemiea Et Cytobiologica,2011,49 :26-33.
  • 2Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene Survivin, expressed in caneer and lymphoma. Nature Medicine, 1997,3:917-921.
  • 3Petrarca CR, Brunetto AT, Duval V, et al. Survivin as a predictive biomar- ker of complete pathologic response to neoadjuvant chemotherapy in patients with stage II and stage III breast cancer. Clinical Breast Cancer, 2011,11:129-134.
  • 4熊慧华,于世英,夏曙,庄亮.survivin基因在乳腺癌组织中的表达及其与HER-2、p53的关系[J].肿瘤防治研究,2005,32(11):707-709. 被引量:3
  • 5Ehon R, Karin J, Darran P, et al. Validation of cytoplasmic-to-nuclear ra- tio of survivin as an indicator of improved prognosisin breast cancer. BMC cancer,2010,10 : 639-650.
  • 6Doo MS, Sung YK, Moo JB, et al. Expression of survivin and clinical cor- relation in patients with breast cancer. Biomedicine & Pharmacotherapy, 2006,60 : 289 -292.
  • 7郝岗平,杜希华,尤勇,侯福林,范志强,张慧娟.不同因素对离体培养的银杏幼茎腋芽生长发育的影响[J].林业科学研究,2000,13(2):217-221. 被引量:24
  • 8Zohny SF, El-Shinawi M. Significance of survivin and Bcl-2 homologous antagonist/killer mRNA in detection of bone metastasis in patients with breast cancer. Medical Oncology ,2011,28 : 108-114.
  • 9Chang Y, Jennifer L, Davis S, et al. Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation. Cancer Discovery,2013,3:212-223.
  • 10Jha K, Shukla M, Pandey M. Survivin expression and targeting in breast cancer. Surgical Oncology,2012,21:125-131.

二级参考文献45

  • 1王文武,欧阳学农,张霞,姜浩.Survivin与bcl-2基因反义寡核酸联合对人乳腺癌裸鼠皮下移植瘤的治疗作用[J].中国临床药理学与治疗学,2006,11(10):1164-1167. 被引量:1
  • 2Biganzoli L, Minisini A, Aapro M, et al. Chemotherapy for metastatic breast cancer[J]. Curr Opin Obstet Gynecol, 2004, 16(7):37-41.
  • 3Jones SE, Erban J, Ovemoyer B, et al. Randomized phase Ⅲ study of docetaxel compared with paclitax el in metastatic breast cancer[J]. Clin Oncol, 2005, 23(11) :5542-5551.
  • 4Grisko T, Williams A, Turkson J, et al. Persistent activation of state signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells[J]. Clin Cancer Res, 2006, 12(6) :11--19.
  • 5Banerjee A. Increased levels of tyrosinated alphabeta (lid and beta(Ⅲ) tubulin isotypes in paclitax- el- resistant MCF-7 breast cancer cells[J]. Biochem Biophys Res Commun, 2002, 293(21):598--601.
  • 6Bieanzoli L, Minisini A, Aapro M, et al. Chemotherapy for metastatic breast cancer[J]. Curr Opin Obstet Gynecol, 2004, 16(9) :37-41.
  • 7Khan MA, Carducci MA, Partin AW. The evolving role of docetaxel in the management of androgen in- dependent prostate cancer[J]. J Urol, 2003, 170 (12) :1709-1716.
  • 8Campone M, Blasinska-Morawiec M, Tekiela A, et al. Phase II study of vinorelbine (altemating intra- venous and oraD in combination with docetaxel as first-line chemotherapy in metastatic breast cancer [J]. CancerChemother PharmacoI, 2009, 63(18): 937--943.
  • 9Kappler M, Rot S, Taubert H, et al. The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tis sue sarcoma cells in vitro under different oxygenconditions[J]. Cancer Gene Ther, 2007, 14(5): 994--1001.
  • 10Altieri DC. Validating survivin as a cancer therapeutic target[J]. Nat Rev Cancer, 2003, 3(8):46-54.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部